Publications of Martin Peifer
All genres
Journal Article (32)
2023
Journal Article
4 (1), pp. 78 - 97 (2023)
Distinct genetically determined origins of Myd88/BCL2-driven aggressive lymphoma rationalize targeted therapeutic intervention strategies. Blood Cancer Discovery 2022
Journal Article
21 (5), pp. 821 - 830 (2022)
CD74-NRG1 fusions are oncogenic in vivo and induce therapeutically tractable ERBB2:ERBB3 heterodimerization. Molecular Cancer Therapeutics 2021
Journal Article
137 (5), pp. 646 - 660 (2021)
Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1. Blood 2020
Journal Article
34 (3), pp. 771 - 786 (2020)
ATM activity in T cells is critical for immune surveillance of lymphoma in vivo. Leukemia: the Journal of Normal and Malignant Hemopoiese ; Official Journal of the Leukemia Research Fund U.K. 2017
Journal Article
8 (1), 153 (2017)
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia. Nature Communications
Journal Article
6 (3), e1320626 (2017)
Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression. Oncoimmunology 2016
Journal Article
15 (3), pp. 311 - 312 (2016)
Telomere maintenance is pivotal for high-risk neuroblastoma. Cell Cycle 2015
Journal Article
16, 7 (2015)
Identification of novel fusion genes in lung cancer using breakpoint assembly of transcriptome sequencing data. Genome Biology
Journal Article
526 (7575), pp. 700 - 704 (2015)
Telomerase activation by genomic rearrangements in high-risk neuroblastoma. Nature 2014
Journal Article
4 (4), pp. 415 - 422 (2014)
CD74-NRG1 fusions in lung adenocarcinoma. Cancer Discovery
Journal Article
4 (2), pp. 246 - 257 (2014)
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer. Cancer Discovery 2013
Journal Article
123 (4), pp. 1732 - 1740 (2013)
Tumor vegf:vegfr2 autocrine feed-forward loop triggers angiogenesis in lung cancer. Journal of Clinical Investigation
Journal Article
5 (209), 209ra153 (2013)
A genomics-based classification of human lung tumors. Science Translational Medicine 2012
Journal Article
51 (1), pp. 54 - 65 (2012)
Systematic screen for tyrosine kinase rearrangements identifies a novel C6orf204-PDGFRB fusion in a patient with recurrent T-ALL and an associated myeloproliferative neoplasm. Genes Chromosomes and Cancer
Journal Article
18 (17), pp. 4682 - 4690 (2012)
Differential protein stability and ALK inhibitor sensitivity of EML4-ALK fusion variants. Clinical Cancer Research
Journal Article
4 (141), 141ra91 (2012)
Targeted expression of mutated ALK induces neuroblastoma in transgenic mice. Science Translational Medicine
Journal Article
44 (10), pp. 1104- - 11xx (2012)
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nature Genetics
Journal Article
109 (42), pp. 17034 - 17039 (2012)
A framework for identification of actionable cancer genome dependencies in small cell lung cancer. Proceedings of the National Academy of Sciences of the United States of America
Journal Article
489 (7417), pp. 519 - 525 (2012)
Comprehensive genomic characterization of squamous cell lung cancers. Nature 2011
Journal Article
1 (1), pp. 78 - 89 (2011)
Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. Cancer Discovery